Drug for relieving pseudomonas aeruginosa keratitis
A technology of Pseudomonas aeruginosa and Pseudomonas aeruginosa, applied in the fields of microbiology and ophthalmology, can solve problems such as corneal perforation, irreversible tissue, damage, etc., and achieve the effect of alleviating the disease, inhibiting proliferation and virulence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0018] The present invention will be further described below in combination with specific embodiments and accompanying drawings.
[0019] A medicine for alleviating Pseudomonas aeruginosa corneal inflammation, comprising a β2 adrenergic receptor inhibitor, the structure of the β2 adrenergic receptor inhibitor is:
[0020]
[0021] By administering the β2 adrenergic receptor inhibitor ICI118551, the bacterial proliferation and virulence expression of Pseudomonas aeruginosa in the cornea were inhibited, and the number of infiltrating neutrophils and the expression of inflammatory factors in the cornea were reduced to reduce the severity of keratitis.
[0022] Tissue damage will lead to increased secretion of catecholamines in the body and increase the infection rate of opportunistic infections. Norepinephrine is a type of catecholamines. Studies have shown that norepinephrine can aggravate infections by promoting the proliferation and virulence of Pseudomonas aeruginosa , In ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com